[Federal Register Volume 86, Number 236 (Monday, December 13, 2021)]
[Notices]
[Page 70866]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-26907]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-932]


Bulk Manufacturer of Controlled Substances Application: SpecGX, 
LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: SpecGX, LLC, has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before February 11, 
2022. Such persons may also file a written request for a hearing on the 
application on or before February 11, 2022.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on September 20, 2021, SpecGX LLC, 3600 North 2nd 
Street, Saint Louis, Missouri 63147, applied to be registered as a bulk 
manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
                                          Drug
          Controlled substance            code           Schedule
------------------------------------------------------------------------
Phenylacetone..........................    8501  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substance in bulk for conversion to other controlled substances. No 
other activity for this drug code is authorized for this registration.

Brian S. Besser,
Acting Assistant Administrator.
[FR Doc. 2021-26907 Filed 12-10-21; 8:45 am]
BILLING CODE P